Topical diphencyprone immunotherapy for cutaneous metastatic melanoma
- 4 November 2009
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 50 (4) , 266-271
Abstract
Topical immunotherapy with contact sensitizers for metastatic melanoma was first reported more than 30 years ago. Diphencyprone (DPCP) immunotherapy is frequently used to treat cutaneous warts and alopecia areata, and we have previously reported the use of DPCP as a single agent to successfully treat extensive, radiotherapy‐resistant melanoma metastases on the scalp. We now report DPCP treatment of a further six patients with cutaneous metastatic melanoma. Of seven patients treated with DPCP thus far, four have demonstrated complete responses of their cutaneous lesions and three have had partial responses. The treatment was well‐tolerated by all patients. Topical immunotherapy with DPCP is inexpensive and relatively non‐invasive and should be considered in patients with locally advanced skin metastases that are unsuitable for other therapies.Keywords
This publication has 12 references indexed in Scilit:
- Chemoablation of metastatic melanoma using intralesional Rose BengalMelanoma Research, 2008
- The therapeutic use of topical contact sensitizers in benign dermatosesBritish Journal of Dermatology, 2008
- Treatment of extensive cutaneous metastatic melanoma with topical diphencyproneJournal of the American Academy of Dermatology, 2007
- Topical Immunotherapy with Diphenylcyclopropenone in Combination with DTIC and Radiation for Cutaneous Metastases of MelanomaDermatology, 2005
- Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: A report of 5 cases and assessment of the literature and diagnostic criteriaJournal of the American Academy of Dermatology, 2005
- Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune responseCancer Immunology, Immunotherapy, 2002
- The therapeutic use of topical contact sensitizers in benign dermatosesBritish Journal of Dermatology, 2001
- Spontaneous Regression of Metastatic MelanomaAnnals of Plastic Surgery, 1991
- REGRESSION OF CUTANEOUS METASTATIC MALIGNANT MELANOMA WITH TOPICAL DIPHENCYPRONE AND ORAL CIMETIDINEThe Lancet, 1989
- The role of immunotherapy in the management of patients with malignant melanomaWorld Journal of Surgery, 1979